Matrix metalloproteinases in exercise and obesity

Review, Article English OPEN
Jaoude, Jonathan ; Koh, Yunsuk (2016)
  • Publisher: Dove Medical Press
  • Journal: Vascular Health and Risk Management, volume 12, pages 287-295 (issn: 1176-6344, eissn: 1178-2048)
  • Related identifiers: doi: 10.2147/VHRM.S103877, pmc: PMC4948699
  • Subject: cardiovascular disease | RC666-701 | Diseases of the circulatory (Cardiovascular) system | Review | collagenases | gelatinases | TIMP | Vascular Health and Risk Management

Jonathan Jaoude,1 Yunsuk Koh2 1Department of Biology, 2Department of Health, Human Performance, and Recreation, Baylor University, Waco, TX, USA Abstract: Matrix metalloproteinases (MMPs) are zinc- and calcium-dependent endoproteinases that have the ability to break down extracellular matrix. The large range of MMPs’ functions widens their spectrum of potential role as activators or inhibitors in tissue remodeling, cardiovascular diseases, and obesity. In particular, MMP-1, -2, and -9 may be associated with exercise and obesity. Thus, the current study reviewed the effects of different types of exercise (resistance and aerobic) on MMP-1, -2, and -9. Previous studies report that the response of MMP-2 and -9 to resistance exercise is dependent upon the length of exercise training, since long-term resistance exercise training increased both MMP-2 and -9, whereas acute bout of resistance exercise decreased these MMPs. Aerobic exercise produces an inconsistent result on MMPs, although some studies showed a decrease in MMP-1. Obesity is related to a relatively lower level of MMP-9, indicating that an exercise-induced increase in MMP-9 may positively influence obesity. A comprehensive understanding of the relationship between exercise, obesity, and MMPs does not exist yet. Future studies examining the acute and chronic responses of these MMPs using different subject models may provide a better understanding of the molecular mechanisms that are associated with exercise, obesity, and cardiovascular disease. Keywords: cardiovascular disease, gelatinases, collagenases, TIMP
  • References (69)
    69 references, page 1 of 7

    1. Gross J, Lapiere CM. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A. 1962;48:1014-1022.

    2. Eisen AZ, Jeffrey JJ, Gross J. Human skin collagenase. Isolation and mechanism of attack on the collagen molecule. Biochim Biophys Acta. 1968;151(3):637-645.

    3. Renaud S, Leppert D. Matrix metalloproteinases in neuromuscular disease. Muscle Nerve. 2007;36(1):1-13.

    4. Nagase H, Woessner JF, Jr. Matrix metalloproteinases. J Biol Chem. 1999;274(31):21491-21494.

    5. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C. Human and mouse proteases: a comparative genomic approach. Nat Rev Genet. 2003; 4(7):544-558.

    6. Sekhon B. Matrix metalloproteinase - an overview. Res Rep Biol. 2010; 1:1-20.

    7. Chaudhary AK, Singh M, Bharti AC, Asotra K, Sundaram S, Mehrotra R. Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. J Biomed Sci. 2010;17:10.

    8. Kadoglou NP, Liapis CD. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr Med Res Opin. 2004;20(4):419-432.

    9. Cho C, Bunch DO, Faure JE, et al. Fertilization defects in sperm from mice lacking fertilin beta. Science. 1998;281(5384):1857-1859.

    10. Van Wart HE, Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A. 1990;87(14):5578-5582.

  • Related Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark